Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold

Stock Track05-14

Tango Therapeutics Inc. (TNGX) experienced a significant pre-market decline of 6.70% on Thursday, as the stock faced selling pressure during early trading hours.

The downward movement appears to be primarily driven by a rating change from Jefferies, which downgraded Tango Therapeutics from "Buy" to "Hold" while simultaneously raising its price target to $27 from $18. This mixed signal, with a more cautious investment rating despite a higher valuation estimate, may have prompted investor concerns and triggered the pre-market sell-off.

Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103571522?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 20:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103571522","market":"nz","top_or_hot":-1,"title":"Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold","media":"Stock Track","content":"<p>Tango Therapeutics Inc. (TNGX) experienced a significant pre-market decline of 6.70% on Thursday, as the stock faced selling pressure during early trading hours.</p><p>The downward movement appears to be primarily driven by a rating change from Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal, with a more cautious investment rating despite a higher valuation estimate, may have prompted investor concerns and triggered the pre-market sell-off.</p><p>Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in pre-market trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tango Therapeutics Plunges 6.7% in Pre-market Following Jefferies Downgrade to Hold\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 20:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tango Therapeutics Inc. (TNGX) experienced a significant pre-market decline of 6.70% on Thursday, as the stock faced selling pressure during early trading hours.</p><p>The downward movement appears to be primarily driven by a rating change from Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal, with a more cautious investment rating despite a higher valuation estimate, may have prompted investor concerns and triggered the pre-market sell-off.</p><p>Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in pre-market trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNGX","symbol_name":"Tango Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1103571522","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103571522","pubTimestamp":1778761765,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tango Therapeutics Inc. (TNGX) experienced a significant pre-market decline of 6.70% on Thursday, as the stock faced selling pressure during early trading hours.The downward movement appears to be...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNGX":"Tango Therapeutics Inc."},"translate_title":"个股追踪|Jefferies下调评级至持有后Tango Therapeutics盘前暴跌6.7%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNGX":1},"content_text":"Tango Therapeutics Inc. (TNGX) experienced a significant pre-market decline of 6.70% on Thursday, as the stock faced selling pressure during early trading hours.The downward movement appears to be primarily driven by a rating change from Jefferies, which downgraded Tango Therapeutics from \"Buy\" to \"Hold\" while simultaneously raising its price target to $27 from $18. This mixed signal, with a more cautious investment rating despite a higher valuation estimate, may have prompted investor concerns and triggered the pre-market sell-off.Other analysts maintained positive views on the stock, with Wedbush raising its target price to $33 from $19 and Canaccord Genuity reaffirming its Buy rating. However, the Jefferies downgrade to a neutral stance seems to have outweighed these optimistic assessments in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103571522","isCrawlerRequest":true}